Biomea Fusion, Inc. (BMEA) has 23 open-market insider trades by 8 insiders since 2021. The most active filer is A2A Pharmaceuticals, Inc., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| A2A Pharmaceuticals, Inc. | 10% Owner | — | 7 | $22.3M | 2023-06-01 |
| Cormorant Asset Management, LP | Dir10% Owner | — | 1 | $15.3M | 2021-04-20 |
| Cormorant Global Healthcare Master Fund, LP | Dir10% Owner | — | 1 | $12.0M | 2023-03-30 |
| Thomas Andrew Butler | CEO | — | 2 | $3.6M | 2021-08-23 |
| Rainer M. Erdtmann | PresCOO | — | 5 | $808K | 2025-12-11 |
| Sotirios Stergiopoulos | Dir | — | 1 | $760K | 2021-09-17 |
| Michael J.m. Hitchcock | CEO | — | 3 | $239K | 2025-12-02 |
| Franco Valle | CFO | — | 3 | $229K | 2024-11-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Rainer M. Erdtmann | — | Buy | $43K | 2025-12-11 |
| Michael J.m. Hitchcock | CEO | Buy | $99K | 2025-12-02 |
| Rainer M. Erdtmann | — | Buy | $55K | 2025-11-28 |
| Michael J.m. Hitchcock | Director | Buy | $101K | 2024-09-30 |
| Franco Valle | CFO | Buy | $111K | 2024-06-11 |
| A2A Pharmaceuticals, Inc. | 10% Owner | Sell | $4.3M | 2023-05-31 |
Companies that share insiders with BMEA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| A2A Pharmaceuticals, Inc. | 10% Owner | Sell | $1.7M | 2023-05-12 |
| A2A Pharmaceuticals, Inc. | 10% Owner | Sell | $8.6M | 2023-05-08 |
| A2A Pharmaceuticals, Inc. | 10% Owner | Sell | $5.8M | 2023-04-20 |
| A2A Pharmaceuticals, Inc. | 10% Owner | Sell | $6.3M | 2023-03-31 |
| Cormorant Global Healthcare Master Fund, LP | Director & 10% Owner | Buy | $12.0M | 2023-03-30 |
| Michael J.m. Hitchcock | Director | Buy | $40K | 2022-11-14 |
| Franco Valle | CFO | Buy | $31K | 2022-11-11 |
| A2A Pharmaceuticals, Inc. | 10% | Buy | $426K | 2022-08-16 |
| A2A Pharmaceuticals, Inc. | 10% Owner | Sell | $777K | 2022-07-21 |